Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/1/2025

Management of Acute Inflammatory Back Pain

First-Line Treatment

  • The American College of Physicians recommends using NSAIDs at the lowest effective dose for the shortest duration necessary to minimize adverse effects 1
  • Acetaminophen (up to 4g/day) is a reasonable first-line option, particularly for patients with cardiovascular risk factors, as recommended by the American Heart Association 2

Alternative First-Line Option

  • Acetaminophen has a slightly weaker analgesic effect than NSAIDs but a more favorable safety profile, according to the American College of Physicians 1
  • The standard dosage of acetaminophen is up to 4g daily (typically 1000 mg every 6 hours), as recommended by the American Academy of Family Physicians 1

Second-Line Treatment

  • Muscle relaxants can be considered for short-term relief when NSAIDs or acetaminophen provide inadequate pain control, as suggested by the American College of Emergency Physicians 1, 3
  • Muscle relaxants are associated with central nervous system adverse effects, primarily sedation, according to the American Academy of Neurology 1

Third-Line Treatment

  • Opioids should only be considered for severe, disabling pain not controlled with acetaminophen and NSAIDs, as recommended by the American College of Emergency Physicians 1, 4
  • Short-acting opioid formulations with recommended starting doses include Hydrocodone/APAP: 5-15 mg every 4-6 hours as needed, Oxycodone: 5-15 mg every 4-6 hours as needed, and Tramadol: 50 mg every 4-6 hours, according to the American Geriatrics Society 3, 5

Important Considerations

  • NSAIDs are associated with gastrointestinal, renal, and cardiovascular risks, as reported by the American College of Physicians 1
  • For patients with cardiovascular risk factors, acetaminophen should be preferred over NSAIDs, as recommended by the American Heart Association 2

Monitoring and Precautions

  • Assess cardiovascular and gastrointestinal risk factors before prescribing NSAIDs, as suggested by the American College of Physicians 1
  • Consider co-administration with a proton-pump inhibitor in higher-risk patients, according to the American Gastroenterological Association 1
  • Limit opioid prescriptions to the lowest practical dose for a limited duration (e.g., 1 week), as recommended by the American College of Emergency Physicians 4
  • Regular reassessment of pain control and medication effectiveness is essential, as emphasized by the American Medical Association 2

Management of Acute Lower Back Pain with Paracetamol and Orphenadrine Citrate

Rationale for Combination Therapy

  • The American College of Physicians recommends paracetamol as a first-line analgesic for acute low back pain, with a favorable safety profile compared to NSAIDs 6
  • Paracetamol remains reasonable due to its safety profile and low cost, despite limited efficacy as monotherapy 6

Safety Considerations

  • The American College of Physicians notes that central nervous system adverse effects, primarily sedation, are common with muscle relaxants like orphenadrine 6
  • Monitor for hepatotoxicity risk with paracetamol, as asymptomatic aminotransferase elevations can occur at 4g/day even in healthy adults 6

Duration of Therapy

  • The American College of Physicians recommends skeletal muscle relaxants, including orphenadrine, only for short-term relief of acute low back pain, typically 2-4 weeks 6
  • Reassess after 1-2 weeks; if no improvement, consider alternative therapies 6

When to Avoid This Combination

  • Consider NSAIDs instead of paracetamol if the patient has no cardiovascular, gastrointestinal, or renal risk factors, as NSAIDs provide superior pain relief compared to paracetamol 7, 8
  • NSAIDs are more effective than paracetamol for acute low back pain, though with higher adverse event risk 9

Monitoring Plan

  • Assess pain relief and functional improvement within 3-7 days 6
  • If inadequate response after 2 weeks, discontinue orphenadrine and consider NSAIDs or physical therapy 6

REFERENCES

2

Management of Chronic Low Back Pain in Patients with Cardiovascular History [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

pharmacological management of persistent pain in older persons. [LINK]

Journal of the American Geriatrics Society (JAGS), 2009